BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30679726)

  • 41. A genomic variant in IRF9 is associated with serum cytokine levels in pig.
    Wang W; Liu Y; Wang H; Ding X; Liu J; Yu Y; Zhang Q
    Immunogenetics; 2016 Jan; 68(1):67-76. PubMed ID: 26518782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. STAT3 controls matrix metalloproteinase-1 expression in colon carcinoma cells by both direct and AP-1-mediated interaction with the MMP-1 promoter.
    Zugowski C; Lieder F; Müller A; Gasch J; Corvinus FM; Moriggl R; Friedrich K
    Biol Chem; 2011 May; 392(5):449-59. PubMed ID: 21410405
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular cloning and characterization of interferon regulatory factor 9 (IRF9) in Japanese flounder, Paralichthys olivaceus.
    Hu GB; Zhao MY; Lin JY; Liu QM; Zhang SC
    Fish Shellfish Immunol; 2014 Aug; 39(2):138-44. PubMed ID: 24837327
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Roles of unphosphorylated ISGF3 in HCV infection and interferon responsiveness.
    Sung PS; Cheon H; Cho CH; Hong SH; Park DY; Seo HI; Park SH; Yoon SK; Stark GR; Shin EC
    Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10443-8. PubMed ID: 26216956
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Jak-STAT3 pathway triggers DICER1 for proteasomal degradation by ubiquitin ligase complex of CUL4A(DCAF1) to promote colon cancer development.
    Ren W; Shen S; Sun Z; Shu P; Shen X; Bu C; Ai F; Zhang X; Tang A; Tian L; Li G; Li X; Ma J
    Cancer Lett; 2016 Jun; 375(2):209-220. PubMed ID: 26965998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activated STAT3 may participate in tumor progression through increasing CD133/survivin expression in early stage of colon cancer.
    Li W; Lee MR; Kim T; Kim YW; Cho MY
    Biochem Biophys Res Commun; 2018 Feb; 497(1):354-361. PubMed ID: 29432737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural and functional characterization of salmon STAT1, STAT2 and IRF9 homologs sheds light on interferon signaling in teleosts.
    Sobhkhez M; Skjesol A; Thomassen E; Tollersrud LG; Iliev DB; Sun B; Robertsen B; Jørgensen JB
    FEBS Open Bio; 2014; 4():858-71. PubMed ID: 25379383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer.
    Sirkisoon SR; Carpenter RL; Rimkus T; Anderson A; Harrison A; Lange AM; Jin G; Watabe K; Lo HW
    Oncogene; 2018 May; 37(19):2502-2514. PubMed ID: 29449694
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.
    Mukherjee A; Di Bisceglie AM; Ray RB
    J Virol; 2015 Mar; 89(6):3356-65. PubMed ID: 25589644
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Porcine bocavirus NP1 negatively regulates interferon signaling pathway by targeting the DNA-binding domain of IRF9.
    Zhang R; Fang L; Wang D; Cai K; Zhang H; Xie L; Li Y; Chen H; Xiao S
    Virology; 2015 Nov; 485():414-21. PubMed ID: 26342467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. STAT3 repressed USP7 expression is crucial for colon cancer development.
    Yang Z; Huo S; Shan Y; Liu H; Xu Y; Yao K; Li X; Zhang X
    FEBS Lett; 2012 Sep; 586(19):3013-7. PubMed ID: 22750444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interferon regulatory factor 9 protects against cardiac hypertrophy by targeting myocardin.
    Jiang DS; Luo YX; Zhang R; Zhang XD; Chen HZ; Zhang Y; Chen K; Zhang SM; Fan GC; Liu PP; Liu DP; Li H
    Hypertension; 2014 Jan; 63(1):119-27. PubMed ID: 24144649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficient killing of SW480 colon carcinoma cells by a signal transducer and activator of transcription (STAT) 3 hairpin decoy oligodeoxynucleotide--interference with interferon-gamma-STAT1-mediated killing.
    Tadlaoui Hbibi A; Laguillier C; Souissi I; Lesage D; Le Coquil S; Cao A; Metelev V; Baran-Marszak F; Fagard R
    FEBS J; 2009 May; 276(9):2505-15. PubMed ID: 19476491
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of XAF1 expression in human colon cancer cell by interferon beta: activation by the transcription regulator STAT1.
    Sun Y; Qiao L; Xia HH; Lin MC; Zou B; Yuan Y; Zhu S; Gu Q; Cheung TK; Kung HF; Yuen MF; Chan AO; Wong BC
    Cancer Lett; 2008 Feb; 260(1-2):62-71. PubMed ID: 18035482
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell cycle and apoptotic effects of SAHA are regulated by the cellular microenvironment in HCT116 multicellular tumour spheroids.
    Lobjois V; Frongia C; Jozan S; Truchet I; Valette A
    Eur J Cancer; 2009 Sep; 45(13):2402-11. PubMed ID: 19553104
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduction in p48-ISGFgamma levels confers resistance to interferon-alpha2a in MHCC97 cells.
    Wu WZ; Sun HC; Gao YQ; Li Y; Wang L; Zhou K; Liu KD; Iliakis G; Tang ZY
    Oncology; 2004; 67(5-6):428-40. PubMed ID: 15714000
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IRF9-Stat2 Fusion Protein as an Innate Immune Inducer to Activate Mx and Interferon-Stimulated Gene Expression in Zebrafish Larvae.
    Huang CJ; Chou CM; Lien HW; Chu CY; Ho JY; Wu Y; Cheng CH
    Mar Biotechnol (NY); 2017 Jun; 19(3):310-319. PubMed ID: 28500614
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression and functional characterization of interferon regulatory factors (irf2, irf7 and irf9) in the blunt snout bream (Megalobrama amblycephala).
    Zhan FB; Liu H; Lai RF; Jakovlić I; Wang WM
    Dev Comp Immunol; 2017 Feb; 67():239-248. PubMed ID: 27677680
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of monoclonal antibodies against GBF1 and their use in studying its functions.
    Roy SK; Hu J; Meng Q; Hu J; Reddy SP; Kalvakolanu DV
    J Interferon Cytokine Res; 2005 Nov; 25(11):666-73. PubMed ID: 16318580
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interferon Regulatory Factor 9 Promotes Lung Cancer Progression via Regulation of Versican.
    Brunn D; Turkowski K; Günther S; Weigert A; Muley T; Kriegsmann M; Winter H; Dammann RH; Stathopoulos GT; Thomas M; Guenther A; Grimminger F; Pullamsetti SS; Seeger W; Savai R
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33430083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.